METHYL 4-CHLORO-1H-INDAZOLE-6-CARBOXYLATE, 95%, 250mg

3-(4-Bromophenyl)oxetane-3-carboxylic acid, 98%, 500mg

(S)-4-Cbz-Morpholine-3-carboxylic acid, 95.0%, 500mg

2-(2-methylpiperidin-1-yl)propanoic acid, 95.0%, 10g

2-(2-Bromophenyl)acetamide, 95.0%, 5g

1-Boc-4-(Pyrimidin-2-yloxy)piperidine, 95.0%, 5g

Etere diisopropilico, min 98%, per sintesi, stab., 2,5 l, confezione in vetro

5-bromo-2,4-dimethoxybenzaldehyde, 95.0%, 10g

1-tert-Butoxycarbonyl-4-iodopiperidine>97.0%(GC)1g

Carboxy-PEG4-sulfonic acid, 500mg

2,6-Difluoro-3-iodopyridine>98.0%(GC)5g

N-METHYL-N-[(3R)-PYRROLIDIN-3-YL]METHANESULFONAMIDE HCL, 95.0%, 5g

Pyrrole-2-carboxaldehyde>98.0%(GC)5g